These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38952674)

  • 1. Candidate tumor-specific CD8
    Sugita Y; Muraoka D; Demachi-Okamura A; Komuro H; Masago K; Sasaki E; Fukushima Y; Matsui T; Shinohara S; Takahashi Y; Nishida R; Takashima C; Yamaguchi T; Horio Y; Hashimoto K; Tanaka I; Hamana H; Kishi H; Miura D; Tanaka Y; Onoue K; Onoguchi K; Yamashita Y; Stratford R; Clancy T; Yamaguchi R; Kuroda H; Ishibashi H; Okubo K; Matsushita H
    Oncoimmunology; 2024; 13(1):2371556. PubMed ID: 38952674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell sequencing on CD8
    Komuro H; Shinohara S; Fukushima Y; Demachi-Okamura A; Muraoka D; Masago K; Matsui T; Sugita Y; Takahashi Y; Nishida R; Takashima C; Ohki T; Shigematsu Y; Watanabe F; Adachi K; Fukuyama T; Hamana H; Kishi H; Miura D; Tanaka Y; Onoue K; Onoguchi K; Yamashita Y; Stratford R; Clancy T; Yamaguchi R; Kuroda H; Doi K; Iwata H; Matsushita H
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37544663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.
    Scherpereel A; Grigoriu BD; Noppen M; Gey T; Chahine B; Baldacci S; Trauet J; Copin MC; Dessaint JP; Porte H; Labalette M
    BMC Cancer; 2013 Jul; 13():324. PubMed ID: 23816056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PD-L1/PD-1 pathway promotes dysfunction, but not "exhaustion", in tumor-responding T cells from pleural effusions in lung cancer patients.
    Prado-Garcia H; Romero-Garcia S; Puerto-Aquino A; Rumbo-Nava U
    Cancer Immunol Immunother; 2017 Jun; 66(6):765-776. PubMed ID: 28289860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional characterizations of CD8
    Zhang Y; Li W; Zhai J; Jin Y; Zhang L; Chen C
    Exp Cell Res; 2022 Aug; 417(1):113212. PubMed ID: 35588796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD39 identifies a specific CD8 + T cell population in lung adenocarcinoma-related metastatic pleural effusion.
    Lv LL; Wang HB; Zhang YX; Zhai JW; Shen Y; Qu QX; Chen C
    BMC Immunol; 2023 Dec; 24(1):53. PubMed ID: 38087217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare population of tumor antigen-specific CD4
    Matsuzaki J; Tsuji T; Chodon T; Ryan C; Koya RC; Odunsi K
    J Immunother Cancer; 2019 Jan; 7(1):7. PubMed ID: 30626427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-26 promotes the pathogenesis of malignant pleural effusion by enhancing CD4
    Niu Y; Ye L; Peng W; Wang Z; Wei X; Wang X; Li Y; Zhang S; Xiang X; Zhou Q
    J Leukoc Biol; 2021 Jul; 110(1):39-52. PubMed ID: 33847412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor.
    Pasetto A; Gros A; Robbins PF; Deniger DC; Prickett TD; Matus-Nicodemos R; Douek DC; Howie B; Robins H; Parkhurst MR; Gartner J; Trebska-McGowan K; Crystal JS; Rosenberg SA
    Cancer Immunol Res; 2016 Sep; 4(9):734-43. PubMed ID: 27354337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.
    Li L; Yang L; Wang L; Wang F; Zhang Z; Li J; Yue D; Chen X; Ping Y; Huang L; Zhang B; Zhang Y
    Int J Cancer; 2016 Nov; 139(10):2261-9. PubMed ID: 27459735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 reverses CD8(+) T cell exhaustion in clinical malignant pleural effusion of lung cancer.
    Hu CY; Zhang YH; Wang T; Chen L; Gong ZH; Wan YS; Li QJ; Li YS; Zhu B
    Clin Exp Immunol; 2016 Oct; 186(1):106-14. PubMed ID: 27447482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in microenvironment of lung cancer and pleural effusions by single-cell RNA sequencing.
    Mahmood K; Wang H; Ji Z; Giovacchini CX; Wahidi MM; Dorry M; Shofer SL; Clarke JM; Antonia SJ; Shaz BH; Steadman K; Weinhold KJ; Yi J
    Lung Cancer; 2024 Jul; 193():107847. PubMed ID: 38889499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway.
    Prado-Garcia H; Romero-Garcia S; Morales-Fuentes J; Aguilar-Cazares D; Lopez-Gonzalez JS
    Cancer Immunol Immunother; 2012 Jul; 61(7):1065-80. PubMed ID: 22159518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Malignant Pleural Effusion Resident CD8
    Dhupar R; Okusanya OT; Eisenberg SH; Monaco SE; Ruffin AT; Liu D; Luketich JD; Kammula US; Bruno TC; Lotze MT; Soloff AC
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment.
    Fehlings M; Jhunjhunwala S; Kowanetz M; O'Gorman WE; Hegde PS; Sumatoh H; Lee BH; Nardin A; Becht E; Flynn S; Ballinger M; Newell EW; Yadav M
    J Immunother Cancer; 2019 Sep; 7(1):249. PubMed ID: 31511069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.
    Gros A; Parkhurst MR; Tran E; Pasetto A; Robbins PF; Ilyas S; Prickett TD; Gartner JJ; Crystal JS; Roberts IM; Trebska-McGowan K; Wunderlich JR; Yang JC; Rosenberg SA
    Nat Med; 2016 Apr; 22(4):433-8. PubMed ID: 26901407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
    Linette GP; Becker-Hapak M; Skidmore ZL; Baroja ML; Xu C; Hundal J; Spencer DH; Fu W; Cummins C; Robnett M; Kaabinejadian S; Hildebrand WH; Magrini V; Demeter R; Krupnick AS; Griffith OL; Griffith M; Mardis ER; Carreno BM
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23662-23670. PubMed ID: 31685621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.